Personal information

Australia, South Africa

Activities

Employment (3)

NSW Health Pathology: Sydney, NSW, AU

2023-03-21 to present | Laboratory lead (Haematology)
Employment
Source: Self-asserted source
Riana van der Linde

New South Wales Health Pathology: Sydney, NSW, AU

2020-03-01 to present | Postgraduate fellow (Haematology)
Employment
Source: Self-asserted source
Riana van der Linde

New South Wales Department of Health: Sydney, New South Wales, AU

2017-06-05 to 2020-01-31 | Advanced trainee (Haematology)
Employment
Source: Self-asserted source
Riana van der Linde

Education and qualifications (6)

The University of Sydney: Sydney, NSW, AU

2021-07-19 to present | Doctor of Philosophy (Medicine and Health)
Education
Source: Self-asserted source
Riana van der Linde

Royal College of Pathologists of Australasia: Surry Hills, NSW, AU

2019-09-10 to present | Fellow (Haematology)
Qualification
Source: Self-asserted source
Riana van der Linde

Colleges of Medicine of South Africa: Rondebosch, ZA

2015-04-01 to present | Fellow (Haematology)
Qualification
Source: Self-asserted source
Riana van der Linde

University of Limpopo: Garankuwa, Limpopo, ZA

2011-01-01 to 2015-06-03 | Master of Medicine (Haematology)
Education
Source: Self-asserted source
Riana van der Linde

University of the Free State: Bloemfontein, Free State, ZA

2012-02-01 to 2014-04-10 | Postgraduate diploma in Transfusion Medicine (Haematology)
Education
Source: Self-asserted source
Riana van der Linde

University of the Free State: Bloemfontein, Free State, ZA

2003-01-01 to 2007-11-30 | Medicine Baccalaureus and Chirurgiae Baccalaureus
Education
Source: Self-asserted source
Riana van der Linde

Professional activities (2)

The University of Sydney: Sydney, NSW, AU

2021-08-01 to present | Clinical lecturer (Sydney Medical School)
Invited position
Source: Self-asserted source
Riana van der Linde

Haematology Society of Australia and New Zealand: Sydney, NSW, AU

2016-01-01 to present
Membership
Source: Self-asserted source
Riana van der Linde

Works (9)

Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia

Pathology
2024-10 | Journal article
Contributors: Maxine Revoltar; Riana van der Linde; Deborah Cromer; Prudence N. Gatt; Sandy Smith; Marian A. Fernandez; Lachlin Vaughan; Emily Blyth; Jennifer Curnow; Elizabeth Tegg et al.
Source: check_circle
Crossref

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year

Cancers
2023-10-19 | Journal article
Contributors: Riana van der Linde; Prudence N. Gatt; Sandy Smith; Marian A. Fernandez; Lachlin Vaughan; Emily Blyth; Jennifer Curnow; David A. Brown; Elizabeth Tegg; Sarah C. Sasson
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Measurable residual disease in adult acute myeloid leukaemia: evaluation of a multidimensional ‘radar’ flow cytometric plot analysis method

Pathology
2023-04 | Journal article
Contributors: Riana van der Linde; Sandy Smith; David A. Brown; Sarah C. Sasson; Elizabeth Tegg
Source: check_circle
Crossref

A twist of fate – lineage switch in acute leukaemia

Pathology
2021-07 | Conference abstract
Part of ISSN: 0031-3025
Source: Self-asserted source
Riana van der Linde

Use of multidimentional flow cytometry plots to improve measurable residual disease monitoring of acute myeloid leukaemias

Pathology
2021-07 | Conference poster
Part of ISSN: 0031-3025
Source: Self-asserted source
Riana van der Linde

Validation of an Acute Myeloid Leukaemia Measurable Residual Disease flow cytometric analysis method using Kaluza software and multidimensional radar plots

ESCCA 2021
2021-04-22 | Conference poster
Source: Self-asserted source
Riana van der Linde

Tranexamic acid to prevent post-partum haemorrhage

Blood Transfusion
2018-07-01 | Journal article
Source: Self-asserted source
Riana van der Linde

Establishing if soluble transferrin receptor and/or serum hepcidin are superior to serum ferritin when determining the iron status of patients with anaemia of chronic disorders at Dr. George Mukhari Academic Hospital.

PathRed Congress 2015
2015-04-01 | Conference poster
Source: Self-asserted source
Riana van der Linde

8p11 Myeloproliferative Syndrome

2013-09-08 | Conference poster
Source: Self-asserted source
Riana van der Linde

Peer review (2 reviews for 1 publication/grant)

Review activity for Pathology. (2)